Skip to content

Gestational Age Specific Thyroid Function Reference Range

Gestational Age Specific Thyroid Function Reference Range in Hong Kong

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03663517
Enrollment
599
Registered
2018-09-10
Start date
2014-07-02
Completion date
2016-04-30
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Reference Values, Thyroid

Keywords

Thyroid, Reference values, Pregnancy

Brief summary

It has been well accepted that maternal thyroid dysfunction has adverse affects on both mothers and fetuses. However, the dramatical changes during pregnancy make the interpretation of thyroid function test (TFT, i.e. free triiodothyronine \[FT3\], free thyroxine \[FT4\] and thyrotropin \[TSH\]) very difficult. Previous studies have shown that the level of thyroid hormones differs from non-pregnant population and varies from gestational ages. Moreover, studies have shown the agreement among different instrument platforms was quite low. This study is aimed to determine gestational age specific TFT reference ranges of the local pregnant population for all available platforms currently used under Hospital Authority and Department of Health.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women receiving pregnancy and postnatal care in the Department of Obstetrics & Gynaecology, Prince of Wales Hospital, Hong Kong

Exclusion criteria

* 1\. Previous history of thyroid dysfunction (hypothyroidism or hyperthyroidism); * 2\. Autoimmune disease, particularly those receiving corticosteroid or immunosuppressant: e.g. systemic lupus erythematosus; * 3\. Disease associated with thyroid dysfunction: e.g. molar pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change of free triiodothyronine (FT3) during pregnancyAt the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.gestational FT3 level
Change of free thyroxine (FT4) during pregnancyAt the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.gestational FT4 level
Change of thyrotropin (TSH) during pregnancyAt the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.gestational TSH level

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026